Actavis, Inc. News Headlines

ACT 
$217.45
*  
1.23
0.56%
Get ACT Alerts
*Delayed - data as of Jul. 25, 2014  -  Find a broker to begin trading ACT now
Exchange: NYSE
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Sector Update: Healthcare Shares Flat Pre-Market; Acorda Could File Patent Infringement Suit
6/26/2014 8:37:44 AM - MT Newswires

Sector Update: Healthcare
6/26/2014 8:37:06 AM - MT Newswires

Sector Update: Financial Stocks Reverse Early Declines, Now Trading Higher; Barclay Said Target of N.Y. State Probe
6/25/2014 3:49:41 PM - MT Newswires

Sector Update: Financial
6/25/2014 3:47:42 PM - MT Newswires

Endo International to Expand Generics Business with DAVA Buy - Analyst Blog
6/25/2014 3:20:00 PM - Zacks.com

Sector Update: Financial Stocks Slightly Lower; Affiliated Managers Gaining After Selection to S&P 500
6/25/2014 1:21:02 PM - MT Newswires

Sector Update: Financial
6/25/2014 12:56:20 PM - MT Newswires

Affiliated Managers Group to Join S&P 500
6/24/2014 6:42:00 PM - Dow Jones Business News

Forest Laboratories Reports Positive Data on Viibryd - Analyst Blog
6/24/2014 6:20:00 PM - Zacks.com

Sector Update: Healthcare Stocks Close Lower Monday; Actavis Adds 2% After Morgan Stanley Boosts Price Target, Investment Rating
6/23/2014 4:07:04 PM - MT Newswires

Sector Update: Healthcare
6/23/2014 4:02:47 PM - MT Newswires

Bloomberg: AbbVie Mulls Another Sweetened Offer For Shire
6/20/2014 11:06:00 AM - RTT News

Teva's Nuvigil Patent Infringement Lawsuits Resolved - Analyst Blog
6/19/2014 4:45:00 PM - Zacks.com

Forest Laboratories Nabs Pediatric Exclusivity for Namenda - Analyst Blog
6/19/2014 1:20:00 PM - Zacks.com

Sector Update: Healthcare
6/19/2014 9:14:21 AM - MT Newswires

Sector Update: Healthcare Shares Flat Pre-Market
6/19/2014 9:12:13 AM - MT Newswires

Actavis Generic Exelon Patch Found to Infringe on Patents
6/19/2014 9:09:00 AM - Dow Jones Business News

Actavis Confirms Court Ruling In Generic Exelon Patch Patent Suit
6/19/2014 9:09:00 AM - RTT News

Wall Street Nervously Awaits FOMC Decision
6/18/2014 6:35:00 AM - RTT News

Actavis, Forest Laboratories Shareholders Approve Merger
6/17/2014 6:18:00 PM - RTT News

Teva Settles Nuvigil Patent Case With Licenses To Sandoz, Actavis, Lupin, Apotex
6/17/2014 8:32:00 AM - RTT News

EUROPE MARKETS: European Stocks Bruised By Iraq Tensions
6/16/2014 12:03:00 PM - Dow Jones Business News

Medtronic To Buy Smaller Rival Covidien In $43 Bln Deal
6/15/2014 10:55:00 PM - RTT News

WSJ: Medtronic In Advanced Talks To Buy Covidien For More Than $40 Bln
6/14/2014 9:59:00 PM - RTT News

Vivus Suit Preserves Exclusivity Of Qsymia - For Now
6/13/2014 2:56:00 PM - Seeking Alpha